FC-binding fragment comprising PD-L1 antigen-binding site
The application relates to specific binding members which bind to programmed death-ligand (PD-L1). The specific binding members preferably comprise a PD-L1antigen-binding site located in structural loops of a constant domain of the specific binding member. The specific binding members find applicati...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | AKELE FREDERICK WOLLERTON VAN HORCK FRANCISCA FIEHLER RYAN FAROUDI MUSTAPHA PRIVEZENTZEV CYRIL TUNA MIHRIBAN BADR FADI |
| description | The application relates to specific binding members which bind to programmed death-ligand (PD-L1). The specific binding members preferably comprise a PD-L1antigen-binding site located in structural loops of a constant domain of the specific binding member. The specific binding members find application, for example, in the treatment of cancer, as well as infectious diseases, inflammation, diseasesand conditions associated with inflammation, and inflammatory diseases.
本申请涉及特异性结合元件，其结合至程序性死亡配体(PD-L1)。该特异性结合元件优选包括位于特异性结合元件的恒定结构域的结构环中的PD-L1抗原结合位点。该特异性结合元件例如在癌症、以及感染性疾病、炎症、与炎症相关联的疾病和病症、及炎性疾病的治疗中获得应用。 |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN111741976A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN111741976A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN111741976A3</originalsourceid><addsrcrecordid>eNrjZLB0c9ZNysxLycxLV0grSkzPTc0rUUjOzy0oyiwGiQW46PoYKiTmlWSmp-bBVRZnlqTyMLCmJeYUp_JCaW4GRTfXEGcP3dSC_PjU4oLE5NS81JJ4Zz9DQ0NzE0NLczNHY2LUAADS5i3L</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>FC-binding fragment comprising PD-L1 antigen-binding site</title><source>esp@cenet</source><creator>AKELE FREDERICK ; WOLLERTON VAN HORCK FRANCISCA ; FIEHLER RYAN ; FAROUDI MUSTAPHA ; PRIVEZENTZEV CYRIL ; TUNA MIHRIBAN ; BADR FADI</creator><creatorcontrib>AKELE FREDERICK ; WOLLERTON VAN HORCK FRANCISCA ; FIEHLER RYAN ; FAROUDI MUSTAPHA ; PRIVEZENTZEV CYRIL ; TUNA MIHRIBAN ; BADR FADI</creatorcontrib><description>The application relates to specific binding members which bind to programmed death-ligand (PD-L1). The specific binding members preferably comprise a PD-L1antigen-binding site located in structural loops of a constant domain of the specific binding member. The specific binding members find application, for example, in the treatment of cancer, as well as infectious diseases, inflammation, diseasesand conditions associated with inflammation, and inflammatory diseases.
本申请涉及特异性结合元件，其结合至程序性死亡配体(PD-L1)。该特异性结合元件优选包括位于特异性结合元件的恒定结构域的结构环中的PD-L1抗原结合位点。该特异性结合元件例如在癌症、以及感染性疾病、炎症、与炎症相关联的疾病和病症、及炎性疾病的治疗中获得应用。</description><language>chi ; eng</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201002&DB=EPODOC&CC=CN&NR=111741976A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201002&DB=EPODOC&CC=CN&NR=111741976A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>AKELE FREDERICK</creatorcontrib><creatorcontrib>WOLLERTON VAN HORCK FRANCISCA</creatorcontrib><creatorcontrib>FIEHLER RYAN</creatorcontrib><creatorcontrib>FAROUDI MUSTAPHA</creatorcontrib><creatorcontrib>PRIVEZENTZEV CYRIL</creatorcontrib><creatorcontrib>TUNA MIHRIBAN</creatorcontrib><creatorcontrib>BADR FADI</creatorcontrib><title>FC-binding fragment comprising PD-L1 antigen-binding site</title><description>The application relates to specific binding members which bind to programmed death-ligand (PD-L1). The specific binding members preferably comprise a PD-L1antigen-binding site located in structural loops of a constant domain of the specific binding member. The specific binding members find application, for example, in the treatment of cancer, as well as infectious diseases, inflammation, diseasesand conditions associated with inflammation, and inflammatory diseases.
本申请涉及特异性结合元件，其结合至程序性死亡配体(PD-L1)。该特异性结合元件优选包括位于特异性结合元件的恒定结构域的结构环中的PD-L1抗原结合位点。该特异性结合元件例如在癌症、以及感染性疾病、炎症、与炎症相关联的疾病和病症、及炎性疾病的治疗中获得应用。</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLB0c9ZNysxLycxLV0grSkzPTc0rUUjOzy0oyiwGiQW46PoYKiTmlWSmp-bBVRZnlqTyMLCmJeYUp_JCaW4GRTfXEGcP3dSC_PjU4oLE5NS81JJ4Zz9DQ0NzE0NLczNHY2LUAADS5i3L</recordid><startdate>20201002</startdate><enddate>20201002</enddate><creator>AKELE FREDERICK</creator><creator>WOLLERTON VAN HORCK FRANCISCA</creator><creator>FIEHLER RYAN</creator><creator>FAROUDI MUSTAPHA</creator><creator>PRIVEZENTZEV CYRIL</creator><creator>TUNA MIHRIBAN</creator><creator>BADR FADI</creator><scope>EVB</scope></search><sort><creationdate>20201002</creationdate><title>FC-binding fragment comprising PD-L1 antigen-binding site</title><author>AKELE FREDERICK ; WOLLERTON VAN HORCK FRANCISCA ; FIEHLER RYAN ; FAROUDI MUSTAPHA ; PRIVEZENTZEV CYRIL ; TUNA MIHRIBAN ; BADR FADI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN111741976A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2020</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><toplevel>online_resources</toplevel><creatorcontrib>AKELE FREDERICK</creatorcontrib><creatorcontrib>WOLLERTON VAN HORCK FRANCISCA</creatorcontrib><creatorcontrib>FIEHLER RYAN</creatorcontrib><creatorcontrib>FAROUDI MUSTAPHA</creatorcontrib><creatorcontrib>PRIVEZENTZEV CYRIL</creatorcontrib><creatorcontrib>TUNA MIHRIBAN</creatorcontrib><creatorcontrib>BADR FADI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>AKELE FREDERICK</au><au>WOLLERTON VAN HORCK FRANCISCA</au><au>FIEHLER RYAN</au><au>FAROUDI MUSTAPHA</au><au>PRIVEZENTZEV CYRIL</au><au>TUNA MIHRIBAN</au><au>BADR FADI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>FC-binding fragment comprising PD-L1 antigen-binding site</title><date>2020-10-02</date><risdate>2020</risdate><abstract>The application relates to specific binding members which bind to programmed death-ligand (PD-L1). The specific binding members preferably comprise a PD-L1antigen-binding site located in structural loops of a constant domain of the specific binding member. The specific binding members find application, for example, in the treatment of cancer, as well as infectious diseases, inflammation, diseasesand conditions associated with inflammation, and inflammatory diseases.
本申请涉及特异性结合元件，其结合至程序性死亡配体(PD-L1)。该特异性结合元件优选包括位于特异性结合元件的恒定结构域的结构环中的PD-L1抗原结合位点。该特异性结合元件例如在癌症、以及感染性疾病、炎症、与炎症相关联的疾病和病症、及炎性疾病的治疗中获得应用。</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_CN111741976A |
| source | esp@cenet |
| subjects | CHEMISTRY METALLURGY ORGANIC CHEMISTRY PEPTIDES |
| title | FC-binding fragment comprising PD-L1 antigen-binding site |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T05%3A27%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=AKELE%20FREDERICK&rft.date=2020-10-02&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN111741976A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |